AZTA - Brooks Automation Sales Growth YoY (Last 12 Months)

Brandmark of Azenta, Inc. (AZTA)

Azenta, Inc. is a recognized leader in biobanking automation, with equipment trusted by the world's leading laboratories. Year-over-year sales dynamics based on TTM methodology clearly demonstrate business resilience, where 4.60 represents the latest metric reading. Modernized plant capacities guarantee asset reliability, although the company is actively resisting the expansion of medical behemoths into its niche.

Sales Growth YoY (TTM): Azenta Life Sciences (AZTA) for 02/11/2024 - 11/17/2026

Summary analytical data breakdowns for Azenta (AZTA)

- market value and analyst target forecast:
Fundamental company valuation:Azenta Life Sciences
Original product of azenta.com

Identifying fundamentally resilient assets requires analyzing continuous business expansion by comparing current revenue with the same period last year. This metric measures the growth rate of cash flow, which for Azenta, Inc. (AZTA) reflects the demand for cryogenic automation within the Life Sciences sector, allowing for an assessment of market position stability through year-over-year sales growth over a rolling four-quarter period.